Relationship of Blood Gas Measurements and Hematological Manifestations of COVID-19 Patients with Mortality: Retrospective Analysis
Abstract
Objective: The aim was to investigate the relationship between blood gas and complete blood count parameters and mortality in patients with COVID-19 during and after in the intensive care unit (ICU).
Material and Methods: Patients were divided as group nonsurvivor and group survivor. Hematological parameters were registered on the day 1, 3, 5.
Results: A total of 142 patients were analyzed retrospectively in the study. Out of them, 46 were women (32%). Seventy-one patients were in group nonsurvivor (50%). The median age of group nonsurvivor patients was 61 years, and the median age of group survivor patients was 60 years. Noninvasive ventilation day and mechanical ventilation day were higher in group nonsurvivor. In group nonsurviver, at the admission to the ICU, in the third day and in the fifth day of ICU, PO2/FiO2 (p<0.001), the lymphocyte count (p<0.001), the monocyte count (p<0.010) and the eosinophil percentages (p<0.025) were lower while the neutrophil-lymphocyte ratio was higher (p<0.001) compared to group survivor. At the admission and in third day of ICU, platelet–lymphocyte ratio were higher in group nonsurvivor than group survivor (p<0.020). At the admission, in the third and the fifth day of ICU, systemic immune-inflammation index were
higher in group nonsurvivor than group survivor (p<0.011). The effects of PO2/FiO2, hematocrit, monocyte percentage, eosinophil count on mortality were found to be significant. The decrease in monocyte percentage increased the probability of mortality 1.6 times.
Conclusion: Changes in blood gas and complete blood count parameters affected the mortality in COVID-19 patients. This study may lead to the development of a more effective treatment strategy by providing a prediction about mortality.
Keywords
COVID-19 , Hematological parameters , Mortality , Intensive care unit
Kaynakça
- World Health Organization. Coronavirus Disease (COVID-19) Outbreak. https://www.who.int. Accessed January 31, 2022.
- Sun X, Wanga T, Cai D, Hu Z, Chen J, Liao H et al. Cytokine storm intervention in the early stages of COVID-19 pneumonia. Cytokine and Growth Factor Rev. 2020;53:38–42.
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult inpatients with COVID- 19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062.
- Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130:2620–2629.
- Lippia G, Plebanib M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 2020;506:145–148.
- Russell CD, Parajuli A, Gale HJ, Bulteel NS, Schuetz P, de Jager CPC et al. The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases: a systematic review and meta-analysis. J Infect. 2019;78 (5):339–348.
- Peng J, Qi D, Yuan G, Deng X, Mei Y, Feng L et al. Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study. J. Clin. Lab. Anal. 2020;34(10): e23475.
- Fois AG, Paliogiannis P, Scano V, Cau S, Babudieri S, Perra R et al. The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients. Molecules. 2020;25(23):5725.
- Kucukcan NE, Kucukcan A. The relationship between hemogram parameters with clinical progress in COVID-19 patients. Dicle Med J. 2020;47(4):763-769
- Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–481. Deng Y, Liu W, Liu K, Fang YY, Shang J, Zhou L et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study. Chin Med J (Engl). 2020;133(11):1261–1267.